7 employees
Medisix Therapeutics is a provider of immune engineering company developing novel cellular therapies.
2018
$20M
from 3 investors over 3 rounds
Medisix Therapeutics Pte Ltd. raised $20M on May 15, 2018
Investors: Osage University Partners (OUP), Lightstone Ventures and Temasek